Latest Breaking News On - Human phase - Page 1 : comparemela.com

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoDamien mcdevittCalifornia institute for regenerative medicineTherapeutics developmentAspen neuroscience incAward will supportMulti patient phaseAutologous neurological therapyAspen neuroscienceCalifornia instituteRegenerative medicineHuman phaseAbla creaseyVice presidentEdward wirth

Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting

Biohaven reported full results from the BHV-7000 Phase 1 study examining doses up to 120 mg daily, demonstrating BHV-7000 was well-tolerated at all doses.

United statesJason lernerJennifer porcelliMike beyerPrnewswire biohaven ltdExchange commissionDeterminants of healthAmerican epilepsy society annual meetingBiohaven therapeutics ltdAmerican epilepsy societySam brown incBiohaven ltdEpilepsy societyAnnual meetingMedical directorEpilepsy clinical lead

Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023

Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023PARIS, France, 02 Nove.

France generalUnited statesSan diegoSan diego convention centerKarine rossignolHaplo ptcyMarina cavazzanaStrategic clinical development advisorCompany protcellAmerican society of hematologySmart immunePresent detailsPioneering clinical studyAmerican societyAnnual meetingT lymphoid progenitors

Basilea announces acquisition of novel clinical-stage

New compound added to Basilea’s clinical pipeline; upon successful completion of preclinical profiling, start of phase 2 study planned for H1 2025Upfront.

Basel stadtSwitzerland generalDavid veitchNils schrMarc engelhardtSwiss exchangeBasilea pharmaceutica international ltdFresh tracks therapeutics incAstellas pharma incHead of corporate communications investor relationsGravitas therapeutics incBasilea pharmaceutica ltdUs food drug administrationPharmaceutica ltdGravitas therapeuticsChief executive officer

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMilind desaiWendy ryanJulie seidelGretchen argastLaura robertsonFarshad farshidfarHeart failure society of americaAdministration of inhibitorsStern investor relations incHypertrophic cardiomyopathy medical societyHypertrophic cardiomyopathy medical society scientific sessionsTenaya therapeutics incCorporate communicationsClinical developmentPresent data